Let's see. On one side we have massive (nearly 1 million participants in all) epidemiological studies done by the most prestigious groups around. Their data shows NO adverse events beyond what would be expected in a general population of women of that age. And in some cases, we actually see fewer events than would be expected.
On the other side, we have a French medical director fired by Merck in an acquisition, who never actually worked for Merck, nor had any inside information of Merck.
I don't know people, but if this were a football game, the "pro-Gardasil" side won the game 153-0.